Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Primary and secondary autoimmune neutropenia Capsoni F; Sarzi-Puttini P; Zanella AArthritis Res Ther 2005[]; 7 (5): 208-14Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious infections and exhibits a self-limited course. Chronic idiopathic neutropenia of adults is characterized by occurrence in late childhood or adulthood, greater prevalence among females than among males, and rare spontaneous remission. Secondary AIN is more commonly seen in adults and underlying causes include collagen disorders, drugs, viruses and lymphoproliferative disorders. In most patients with AIN, antibodies recognize antigens located on the IgG Fc receptor type 3b but other target antigens have been recently identified in secondary AIN. Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies.|Adult[MESH]|Antibodies, Antineutrophil Cytoplasmic/immunology[MESH]|Antibody Specificity[MESH]|Antigens, CD/immunology[MESH]|Autoantigens/immunology[MESH]|Autoimmune Diseases/complications/drug therapy/*immunology/therapy[MESH]|Felty Syndrome/complications[MESH]|Female[MESH]|GPI-Linked Proteins[MESH]|Granulocyte Colony-Stimulating Factor/therapeutic use[MESH]|Hematologic Diseases/blood/complications[MESH]|Humans[MESH]|Immunoglobulins, Intravenous/therapeutic use[MESH]|Infant[MESH]|Isoantigens/immunology[MESH]|Leukemia, Lymphoid/complications[MESH]|Lupus Erythematosus, Systemic/complications[MESH]|Male[MESH]|Neutropenia/drug therapy/etiology/*immunology/therapy[MESH]|Prevalence[MESH]|Receptors, IgG/immunology[MESH]|Rheumatic Diseases/blood/complications[MESH] |